2019 Edward Novitski Prize awarded to Joseph Heitman
Joseph Heitman, MD, PhD of Duke University is the recipient of the 2019 Genetics Society of America (GSA) Edward Novitski Prize. Heitman is honored for his work on human fungal pathogens and for identifying the molecular targets of…
Duke Among Top 10 for Federal Medical Research Funding
Duke University received $384.6 million last year from the National Institutes of Health to advance medical research, ranking 9th in the country among universities, research institutions and teaching hospitals that are awarded the taxpayer-based research…
PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452
PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452
Duke-linked crop science startup Avalo raises $500K, looks for another $600K
DURHAM – Avalo, a Durham-based startup with ties to Duke University, has raised an additional $500,000 from two investors, according to an SEC filing. The company describes itself as “generating crop resilience through gene discovery for a…
Ed Pagani Named Executive Director for Duke External Partnerships
DURHAM, N.C., March 1, 2022 — Ed Pagani, PhD, a longtime industry and technology transfer executive from Michigan, will join Duke University’s Office for Research & Innovation as the first executive director of the Office…
Duke Signed a License Agreement with Splendo Health
Duke University and Splendo Health have entered into a license agreement. The Dutch digital health startup is a collaboration between Duke University and Splendo Consulting. Splendo Health has developed SplendoFit, a comprehensive digital platform with…
DIHI announces 2019 RFA Innovation Awards
Duke Health invests in innovation projects The Duke Institute for Health Innovation (DIHI) has announced that it will support high-potential innovation projects in the areas of population health and analytics, novel patient interactions, new and…
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions
Agreement includes Europe, Commonwealth of Independent States countries, China, India, parts of Latin America and the Oceania countries DURHAM, N.C.–(BUSINESS WIRE), December 7, 2021–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Aerie and Santen have…